Over a week ago | ||||
Hot Stocks
|
Genetron says early liver cancer screening research results cited in guidelines »
07:30 02/09/21 02/0907:30 02/09/2107:30
GTH
Genetron
Genetron announced that… Genetron announced that its early liver cancer screening research results were cited by the "Chinese Anti-Cancer Association Guidelines for Patients with Primary Liver Cancer". The guidelines, issued by the Chinese Anti-Cancer Association, are the first national-level patient-oriented full-process guidelines for liver cancer prevention and treatment in China. In the section on early liver cancer screening, the guidelines emphasized that "Liquid biopsies based on circulating tumor DNA (ctDNA) have shown significant value in early screening for liver cancer. The combined detection of mutation and methylation, in combination with traditional protein biomarkers can achieve better screening results." The liquid biopsy-based early liver cancer screening study, jointly published by Genetron Health and the National Cancer Center/Cancer Hospital Chinese Academy of Medical Sciences in the Proceedings of the National Academy of Sciences, or PNAS, was cited in the guidelines indicating awareness and regard for Genetron's research among the expert community. ShowHide Related Items >><<
|
Over a month ago | ||||
Conference/Events
|
Genetron management to meet virtually with BTIG »
05:55 01/20/21 01/2005:55 01/20/2105:55
GTH
Genetron
Virtual Meetings to be… Virtual Meetings to be held January 19-20 hosted by BTIG. ShowHide Related Items >><<
| |||
Conference/Events
|
Genetron management to meet virtually with BTIG »
04:55 01/19/21 01/1904:55 01/19/2104:55
GTH
Genetron
Virtual Meetings to be… Virtual Meetings to be held January 19-20 hosted by BTIG. ShowHide Related Items >><<
| |||
Conference/Events
|
Genetron management to meet virtually with BTIG »
10:57 01/15/21 01/1510:57 01/15/2110:57
GTH
Genetron
Virtual Meetings to be… Virtual Meetings to be held January 19-20 hosted by BTIG. ShowHide Related Items >><<
| |||
On The Fly
|
Fly Intel: Wall Street's top stories for Wednesday »
16:32 01/06/21 01/0616:32 01/06/2116:32
MRNA
Moderna
China Telecom
China Unicom
China Mobile
Alibaba
Tencent
AmerisourceBergen
Walgreens Boots Alliance
UnitedHealth
Change Healthcare
Tesla
DraftKings
Genetron
Danimer Scientific
Imara
NeoGenomics
Stock futures were mostly… ShowHide Related Items >><<
|
On The Fly
|
Fly Intel: Wall Street's top stories at midday »
12:38 01/06/21 01/0612:38 01/06/2112:38
MRNA
Moderna
China Telecom
China Mobile
China Unicom
AmerisourceBergen
Walgreens Boots Alliance
UnitedHealth
Change Healthcare
Tesla
Genetron
Danimer Scientific
Imara
NeoGenomics
Stock futures were mostly… ShowHide Related Items >><<
|
Hot Stocks
|
Genetron, CTTQ enter exclusive partnership agreement for HCCscreen »
05:08 01/06/21 01/0605:08 01/06/2105:08
GTH
Genetron
Genetron and Chia Tai… Genetron and Chia Tai Tianqing Pharmaceutical, or CTTQ, a subsidiary of Sino Biopharmaceutical, announced an exclusive strategic partnership agreement for HCCscreen, Genetron Health's blood-based early screening test for hepatocellular carcinoma, or HCC, in China. This partnership targets the hospital market in China, with a focus on combatting liver disease, and marks Genetron Health's third commercialization initiative of HCCscreen in the country. Under the agreement, the companies will work together exclusively to co-market and co-promote HCCscreen in the hospital market, covering designated territories in China. The parties intend to target high-risk individuals for HCC, which include HBV-positive carriers, as well as other liver disease patients. Genetron will pay CTTQ a promotional fee based on a percentage of revenues generated from the collaboration. Contingent on certain sales and other requirements, the exclusivity period is expected to last three years. As a result of the agreement, Genetron expects HCCscreen revenues to further accelerate in China. ShowHide Related Items >><<
|
Over a quarter ago | ||||
Hot Stocks
|
Genetron says HCCscreen selected by NCC, Wuxi for public health initiative »
08:04 11/27/20 11/2708:04 11/27/2008:04
GTH
Genetron
Genetron Holdings… Genetron Holdings provided an update for HCCscreen, its blood-based early screening test for hepatocellular carcinoma in China. Led by the Wuxi municipal government and administered by the National Cancer Center in China, the "Liver Cancer Early Screening Comprehensive Prevention and Control Project" is a public health initiative. The goal of the Project is to increase the awareness of liver cancer early screening, and to become a pilot city model in China. For the Project, Wuxi has selected HCCscreen for local residents who are high-risk individuals for HCC, and is committed to administering 150,000 tests over a period of three years. Wuxi had entered into a small-scale collaboration agreement with Genetron Health in 2019, and the Project represents an expanded collaboration between the parties. Wuxi is a city in the southern part of Jiangsu Province in eastern China with a population of over six million people, and has emerged as a biopharma innovation hub in recent years. Separately, Genetron Health has formed a new operating center through a joint venture agreement with Wuxi, in which the parties will closely collaborate on advancing the liver cancer early screening market in China, through the adoption of HCCscreen. Under this joint venture agreement, both parties will contribute capital, and Genetron Health will own 90% of the joint venture. In addition to the commitment of using HCCscreen for its residents, Wuxi will also provide Genetron Health with other supportive measures including rental, R&D subsidies and tax benefits. ShowHide Related Items >><<
| |||
Conference/Events
|
Canaccord to hold a virtual forum »
08:24 11/19/20 11/1908:24 11/19/2008:24
AFIB
Acutus Medical
Apyx Medical
AtriCure
Aspira Women's Health
AxoGen
Castle Biosciences
GenMark
Genetron
InMode
OrthoPediatrics
LeMaitre
Pulmonx
Inari Medical
Penumbra
Insulet
Avita Medical
Sientra
SeaSpine
Tactile Systems
TransMedics
Intersect ENT
Exagen
2020 Medical Technologies… 2020 Medical Technologies & Diagnostics Virtual Forum will be held on November 19. ShowHide Related Items >><<
| |||
Conference/Events
|
Goldman Sachs to hold a virtual conference »
04:55 11/18/20 11/1804:55 11/18/2004:55
GTH
Genetron
Hutchison China MediTech
I-MAB
Asia Pacific Healthcare… Asia Pacific Healthcare Virtual Forum 2020 will be held on November 16-18. ShowHide Related Items >><<
|